GEN2

· GenVivo, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GEN2, covering 2024-11-06 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors [Phase 1]